Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is an investigator initiated prospective open-label, within-patient, masked, randomized
study in patients with neovascular AMD, DME, or RVO undergoing bilateral anti-VEGF
injections. Patients will be randomized into two cohorts (Cohort 1 and Cohort 2) and then
followed for 3 consecutive injection visits. Treatment will be rendered at each injection
visit based on the individualized routine established anti-VEGF injection interval for each
patient.